J
Jorge Sánchez-Guerrero
Researcher at The Feinstein Institute for Medical Research
Publications - 52
Citations - 8082
Jorge Sánchez-Guerrero is an academic researcher from The Feinstein Institute for Medical Research. The author has contributed to research in topics: Lupus erythematosus & Lupus nephritis. The author has an hindex of 25, co-authored 52 publications receiving 6627 citations.
Papers
More filters
Journal ArticleDOI
The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes
Matthew H. Liang,Michael Corzillius,Sang Cheol Bae,Robert A. Lew,Paul R. Fortin,Caroline Gordon,David A. Isenberg,Graciela S. Alarcón,Karin V. Straaton,Judah A. Denburg,Susan D. Denburg,John M. Esdaile,Bonnie I. Glanz,Elizabeth W. Karlson,Shahram Khoshbin,Malcolm P. Rogers,Peter H. Schur,John G. Hanly,Elizabeth Kozora,Sterling G. West,Robert G. Lahita,Michael D. Lockshin,Joseph M. McCune,Patricia M. Moore,Michelle Petri,W. Neal Roberts,Jorge Sánchez-Guerrero,Martin Veilleux,Robin L. Brey,Wayne D. Cornblath,Christopher M. Filley,John D. Fisk,Pontus Harten,Elaine M. Hay,Grant L. Iverson,Steven R. Levine,Elizabeth Waterhouse,Daniel J. Wallace,John B. Winer +38 more
TL;DR: The American College of Rheumatology Nomenclature for NPSLE provides case definitions for 19 neuropsychiatric syndromes seen in SLE, with reporting standards and recommendations for laboratory and imaging tests.
Journal ArticleDOI
Efficacy and safety of rituximab in patients with active proliferative lupus nephritis: The lupus nephritis assessment with rituximab study†
Brad H. Rovin,Richard Furie,Kevin Latinis,R. John Looney,Fernando C. Fervenza,Jorge Sánchez-Guerrero,Romeo Maciuca,David Zhang,J Garg,Paul Brunetta,Gerald B. Appel +10 more
TL;DR: Although rituximab therapy led to more responders and greater reductions in anti-dsDNA and C3/C4 levels, it did not improve clinical outcomes after 1 year of treatment.
Journal ArticleDOI
Mycophenolate Mofetil versus Cyclophosphamide for Induction Treatment of Lupus Nephritis
Gerald B. Appel,Gabriel Contreras,Mary Anne Dooley,Ellen M. Ginzler,David A. Isenberg,David Jayne,Lei Shi Li,Eduardo Mysler,Jorge Sánchez-Guerrero,Neil Solomons,David Wofsy,Carlos Abud,Sharon G. Adler,Graciela S. Alarcón,Elisa N. Albuquerque,Fernando Almeida,Alejandro Alvarellos,Gerald B. Appel,Hilario Avila,Cornelia Blume,Ioannis Boletis,Alain Bonnardeaux,Alan Braun,Jill P. Buyon,Ricard Cervera,Nan Chen,Shun-Le Chen,António Gomes Da Costa,Razeen Davids,David D'Cruz,Enrique de Ramón,Atul Deodhar,Andrea Doria,Bertrand Dussol,Paul Emery,Justus Fiechtner,Jürgen Floege,Hilda Fragoso-Loyo,Richard Furie,Rozina Ghazalli,Cybele Ghossein,Gary S. Gilkeson,EM Ginzler,Caroline Gordon,Jennifer M. Grossman,Jieruo Gu,Loïc Guillevin,Pierre Yves Hatron,Gisela Herrera,Falk Hiepe,Frédéric Houssiau,Osvaldo Hübscher,Claudia Hura,Joshua Kaplan,Gianna Mastroianni Kirsztajn,Emese Kiss,Ghazali Ahmad Kutty,Maurice Laville,Maria Lazaro,Oliver Lenz,Leishi Li,Liz Lightstone,Sam Lim,Michel Malaise,Susan Manzi,Juan Carlos Marcos,Olivier Meyer,Pablo Monge,Saraladev Naicker,Nathaniel Neal,Michael Neuwelt,Kathy Nicholls,Nancy J. Olsen,José Ordi-Ros,Barbara E. Ostrov,Manuel Pestana,Michelle Petri,G. Pokorny,Jacques Pourrat,Jiaqi Qian,Jai Radhakrishnan,Brad H. Rovin,Julio Sanchez Roman,Joseph C. Shanahan,William Shergy,Fotini Skopouli,Alberto Spindler,Christopher Striebich,Robert Sundel,Charles R. Swanepoel,Yen Tan Si,Guillermo Tate,Vladimír Tesaŕ,Mohamed Tikly,Haiyan Wang,Rosnawati Yahya,Xueqing Yu,Fengchun Zhang,Diana Zoruba +98 more
TL;DR: Although most patients in both treatment groups experienced clinical improvement, the study did not meet its primary objective of showing that MMF was superior to IVC as induction treatment for lupus nephritis.
Derivation and Validation of Systemic Lupus International Collaborating Clinics Classification Criteria for Systemic Lupus Erythematosus
M. Petri,A-M Orbai,Graciela S. Alarcón,Caroline Gordon,Joan T. Merrill,PR Fortin,IN Bruce,David A. Isenberg,Daniel J. Wallace,O Nived,Gunnar Sturfelt,Rosalind Ramsey-Goldman,S-C Bae,JG Hanly,Jorge Sánchez-Guerrero,Aileen Clarke,Cynthia Aranow,Susan Manzi,MB Urowitz,Dafna D. Gladman,KC Kalunian,Melissa I. Costner,H Fang,Laurence S. Magder +23 more
TL;DR: The Systemic Lupus International Collaborating Clinics (SLICC) group revised and validated the American College of Rheumatology (ACR) systemic lupus erythematosus (SLE) classification criteria in order to improve clinical relevance, meet stringent methodology requirements, and incorporate new knowledge regarding the immunology of SLE as mentioned in this paper.
Journal ArticleDOI
The reliability of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index in patients with systemic lupus erythematosus.
Dafna D. Gladman,Murray B. Urowitz,Charles H. Goldsmith,Paul R. Fortin,Ellen M. Ginzler,Caroline Gordon,John G. Hanly,David A. Isenberg,Kenneth C. Kalunian,Ola Nived,Michelle Petri,Jorge Sánchez-Guerrero,M L Snaith,Gunnar Sturfelt +13 more
TL;DR: Physicians from different centers are able to assess patients with SLE in a reproducible way, using the SLEDAI to assess disease activity and the SLICC/ACR Damage Index to assess accumulated damage.